fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Obesity-related cancer rising sharply in young Chinese people

Written by | 5 Sep 2024

Rates of obesity-linked cancers in China rose at an alarming 3.6% every year between 2007 and 2021 while non-obesity-related cancers remained stable, according to new data published in… read more.

Abbott and the American Diabetes Association collaborate to drive a better understanding of the role of nutrition formulas to support people with diabetes and obesity

Written by | 24 Aug 2024

The American Diabetes Association® (ADA) and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity, and metabolic dysfunction and how… read more.

Sugar sweetened beverage intake among children and youths shows alarming increases worldwide

Written by | 15 Aug 2024

Children and adolescents (ages 3-19) worldwide consumed on average 23% more sugar sweetened beverages (SSBs) in 2018 than they did in 1990, researchers reported on August 7, 2024… read more.

Study uncovers connections between obesity and heart failure

Written by | 12 Aug 2024

A new small study led by Johns Hopkins Medicine researchers and published July 25th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients having a… read more.

Exploding popularity of Ozempic and Wegovy among privately insured patients may worsen disparities

Written by | 5 Aug 2024

A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with… read more.

Data shows surge in in new GLP-1RA prescriptions for obesity without type 2 diabetes

Written by | 25 Jul 2024

A nationwide study found a marked increase in new GLP-1RA prescriptions over the last decade, particularly since 2020. Semaglutide was the most prescribed GLP-1RA, by far, in 2023…. read more.

Risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients prescribed semaglutide – Novo Nordisk

Written by | 12 Jul 2024

A new observational study reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision… read more.

Genetic study points to oxytocin as possible treatment for obesity and postnatal depression

Written by | 9 Jul 2024

Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioural problems and, in mothers, postnatal depression. The discovery, reported today in Cell, may have wider… read more.

Wegovy (semaglutide) is approved by NMPA (China) for long-term weight management for overweight and obese people – Novo Nordisk

Written by | 30 Jun 2024

Novo Nordisk’s weight-loss drug Wegovy has been approved for sale in China, opening the door to a huge market in which obesity rates have more than doubled among… read more.

Bariatric surgery more effective and durable than new obesity drugs and lifestyle intervention

Written by | 21 Jun 2024

Systematic reviews* of medical literature between 2020 to 2024 show bariatric surgery, also known as metabolic or weight-loss surgery, produces the greatest and most sustained weight loss compared… read more.

Specialist weight-loss services in England unable to keep up with spiralling demand

Written by | 20 Jun 2024

One in six integrated care boards (ICBs) in England have stopped accepting new patients for specialist weight management services as their referral numbers spiral out of control, an… read more.

Price sensitivity to unhealthy foods

Written by | 14 Jun 2024

Consumer data shows people with obesity are more price-sensitive than others when it comes to buying unhealthy foods, suggesting a food tax could be an effective public health… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.